Healy, Gerard M.
Salinas-Miranda, Emmanuel
Jain, Rahi
Dong, Xin
Deniffel, Dominik
Borgida, Ayelet
Hosni, Ali
Ryan, David T.
Njeze, Nwabundo
McGuire, Anne
Conlon, Kevin C.
Dodd, Jonathan D.
Ryan, Edmund Ronan
Grant, Robert C.
Gallinger, Steven
Haider, Masoom A. https://orcid.org/0000-0002-7165-8315
Funding for this research was provided by:
Ontario Institute for Cancer Research
Faculty of Radiologists, Royal College of Surgeons in Ireland
Deutsche Forschungsgemeinschaft (DE 3207/1-1)
Article History
Received: 29 May 2021
Revised: 5 August 2021
Accepted: 31 August 2021
First Online: 10 November 2021
Declarations
:
: The scientific guarantor of this publication is Dr Masoom Haider
: The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.
: Xin Dong and Rahi Jain (both co-authors) kindly provided statistical advice for this manuscript.
: The need for informed consent was waived by research ethics boards.
: Institutional Review Board approval was obtained.
: Fifty-five patients within the North-American cohort have been previously used in a PDAC Radiomics prognostication study which generated three publications.
: • Retrospective• Diagnostic or prognostic study• Performed at multiple institutions